Genomics and multi-omics companies develop technologies, services and analytical platforms that help researchers and clinicians understand biological systems at the DNA, RNA, protein and cellular level. The field underpins advances in precision medicine, drug discovery, diagnostics, agriculture and biotechnology.
This category includes companies working on:
Browse 146 UK genomics and multi-omics companies below.
Mechanobiology platform for target discovery and validation
Mechanome Bio is a Cambridge-based company developing a mechano-transcriptomics platform for biomarker and drug target discovery. The platform combines spatial multi-omics data…
Semiconductor sequencing platform for point-of-need diagnostics
DNA Electronics is a diagnostics company developing a semiconductor-based DNA sequencing platform for rapid, direct-from-specimen genomic analysis at the point of need. Its…
Genome-editing platform mapping cancer drug resistance and druggable vulnerabilities
BASE Rx is a Wellcome Sanger Institute spin-out applying genome-editing and DNA sequencing technologies to cancer drug discovery. The company maps single-base genetic variants to…
Bioinformatics, software and compliance consultancy for biotech companies
Prismea is a provider of bioinformatics, software and cloud consultancy services for biotechnology companies. The company supports biotech clients with data analysis across…
Multiomics platform for cancer biomarker discovery and diagnostics
Tagomics is a Cambridge-based biotech developing a multiomics platform for disease biomarker discovery and diagnostics. Its platform integrates genomics, epigenomics and…
Enzymes, reagents and kits for molecular biology research
New England Biolabs (UK) is the UK subsidiary of New England Biolabs, a global leader in enzymes and reagents for molecular biology research. The Hitchin-based office supplies the…
Non-CRISPR RNA-guided gene editing and modulation platform
Pencil Biosciences is a gene editing company developing a fully synthetic, RNA-guided genome modulation platform as an alternative to CRISPR-based technologies. The system is…
Novel methylation amplification platform for clinical genomic diagnostics
Syndex Bio is a Cambridge-based biotechnology company developing a proprietary platform technology that enables amplification of DNA methylation for the first time. Unlike…
ADC pipeline targeting mutant stem cells in blood cancers
Alethio Therapeutics Limited is a preclinical-stage biotechnology company developing antibody-drug conjugates for myeloproliferative neoplasms, a group of chronic blood cancers.…
Molecular biology reagents and kits for DNA and RNA research
Microzone is a UK manufacturer of molecular biology reagents and kits for DNA and RNA research and diagnostics. The company produces PCR and qPCR mastermixes, direct to PCR sample…
Large-scale genomics research institute advancing human and pathogen biology
The Wellcome Sanger Institute is a genomics research institute on the Wellcome Genome Campus in Hinxton, funded by Wellcome. It made the largest single contribution to the Human…
Patient-controlled DNA biobank platform for precision prescribing insights
GeneHub is a London-based digital health company operating a patient-controlled biobank platform that rewards patients with free DNA tests and insights in exchange for sharing…